Patents/Assignees

Humabs Biomed SA

14 patents in portfolio

US12492240utility2025
Neutralizing Anti-influenza a Antibodies and Uses Thereof
0 cites
US12404318utility2025
Combination HBV Therapy
0 cites
US12325740utility2025
Neutralizing Anti-influenza B Antibodies and Uses Thereof
0 cites
US12312397utility2025
Anti-o2 Antibodies and Uses Thereof
0 cites
US12304946utility2025
Antibodies That Neutralize Hepatitis B Virus and Uses Thereof
0 cites
US12037381utility2024
Antibodies That Potently Neutralize Hepatitis B Virus and Uses Thereof
0 cites
US12018068utility2024
Anti-o1 Antibodies and Uses Thereof
0 cites
US11970527utility2024
Antibody Directed Against S. Aureus Clumping Factor a (clfa)
0 cites
US11932682utility2024
Neutralizing Anti-influenza a Antibodies and Uses Thereof
0 cites
US11926658utility2024
Multispecific Antibodies Specifically Binding to Zika Virus Epitopes
0 cites
US11912757utility2024
Antibodies Specifically Binding to Zika Virus Epitopes and Uses Thereof
0 cites
US11787853utility2023
Neutralizing Anti-influenza B Antibodies and Uses Thereof
0 cites
US11723977utility2023
Broadly Neutralizing Antibodies Directed Against the Rabies Virus Glycoprotein and Uses Thereof
0 cites
US11578119utility2023
Antibodies Directed Against Staphylococcus Aureus Leukotoxins
0 cites